Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivoglitazone phosphate + metformin vs placebo + metformin in type 2 diabetes mellitus
CTR20160943Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivoglitazone in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Dec 2016; status: completed.
02
Drugs
rivoglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20160943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160943.